[Clinico-laboratory studies in oncology].

Area of Science:

• Oncology
• Immunology
• Clinical Medicine

Context:

• Cancer patient management involves assessing treatment efficacy and predicting outcomes.
• Preventing opportunistic infections is crucial for improving cancer patient survival rates.
• Understanding the role of bacterial immunity in cancer patients is essential for supportive care.

Purpose:

• To evaluate the clinical and laboratory response of cancer patients to antitumor therapy, including immunomodulators.
• To explore the utility of specific procedures as prognostic indicators in cancer.
• To investigate bacterial immunity and methods for its stimulation to prevent postoperative complications.

Summary:

• The study presents findings from a clinico-laboratory evaluation of cancer patient responses to various antitumor treatments and immunomodulatory agents.
• It examines the application of certain diagnostic procedures for guiding prognosis in oncology.
• Research on bacterial immunity and strategies to enhance it for preventing purulent complications in cancer patients is discussed.

Impact:

• Provides insights into optimizing cancer treatment strategies by evaluating patient response.
• Offers potential methods for improving patient prognosis through predictive procedures.
• Highlights the importance of immune system support in preventing infections, thereby improving patient outcomes and quality of life.